What did FDA do regarding the sunscreen ingredient?

FDA added bemotrizinol to allowed sunscreen actives

The U.S. Food and Drug Administration expanded sunscreen options for the first time in decades by adding bemotrizinol to the list of permitted sunscreen active ingredients. The change marks a major milestone because bemotrizinol has been used in Europe and Asia, but it had not been allowed for use in the U.S. sunscreen market.

What the approval changes

With bemotrizinol now permitted, U.S. manufacturers can include it in sunscreen formulations as an active ingredient. The reports indicate it provides protection across both ultraviolet ranges—UVA and UVB—matching the broad coverage expectations for modern sunscreens.

Why the timing is noteworthy

The news summary emphasizes that this is the first expansion of permitted sunscreen active ingredients for about 20 years (and at another point describes it as the first new ingredient in more than 25 years). That long gap matters because it suggests the U.S. market had limited regulatory pathways for introducing newer filters.

What consumers should take away

For shoppers, the key practical implication is that future products may appear with bemotrizinol listed among their active ingredients, potentially improving product variety for people seeking specific UV protection filters.

What isn’t detailed in the provided update

The summaries don’t cover pricing, coverage ranges (like SPF-specific performance), product launch timing, or whether the ingredient is approved with particular formulation limits. Those details would typically be found in product labeling and FDA documentation beyond this page’s brief.